The fundamental role of the IMB is to protect and enhance public and animal health through the regulation of human and veterinary medical products. Among its many activities, the IMB regulates clinical trials, as well as monitoring and inspecting products on the market to ensure their safety and efficacy

2011 was particularly significant as it represented the first year of our new five year strategic plan. This plan sets out the IMB’s five high-level strategic goals for this time period.

The five high-level strategic goals are:
1. Enhance healthcare product safety and patient outcomes by effective risk management and market surveillance.
2. Deliver clear, relevant and timely communications to patients, consumers and healthcare professionals.
3. Improve service delivery within a high quality, risk-based regulatory framework.
4. Influence legislation and policy development at European and international levels for the benefit of public and animal health.
5. Build future capabilities to meet evolving regulatory requirements, and scientific and technological advances.